- Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2534361
- Clin Mol Hepatol.
- 2022 Oct;28(4):940-940.
- doi: 10.3350/cmh.2022.0084.e1
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]
-
Kim DY
- KMID: 2534360
- Clin Mol Hepatol.
- 2022 Oct;28(4):939-939.
- doi: 10.3350/cmh.2021.0277.e1
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum to ‘Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023’ [Clin Mol Hepatol 2025;31:e235-e238]
-
Kim D, Loomba R, Ahmed A
- KMID: 2572040
- Clin Mol Hepatol.
- 2025 Oct;31(4):1387-1388.
- doi: 10.3350/cmh.2024.1150e
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]
-
Oh JH, Sinn DH
- KMID: 2544005
- Clin Mol Hepatol.
- 2023 Jul;29(3):828-829.
- doi: 10.3350/cmh.2023.0054e
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum to ‘Correspondence on Letter regarding “Evidencebased hyponatremia management in liver disease”’ [Clin Mol Hepatol 2023;29:1048-1049]
-
Baek SH, Ryu JY, Kim S
- KMID: 2549395
- Clin Mol Hepatol.
- 2024 Jan;30(1):134-134.
- doi: 10.3350/cmh.2023.0261e
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum to ‘Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction’ [Clin Mol Hepatol 2024;30:539-560]
-
Dezhbord M, Kim SH, Park S, Lee DR, Kim N, Won J, Lee AR, Kim DS, Kim KH
- KMID: 2560129
- Clin Mol Hepatol.
- 2024 Oct;30(4):1060-1065.
- doi: 10.3350/cmh.2024.0060e
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum to ‘Systemic therapy in advanced hepatocellular carcinoma’ [Clin Mol Hepatol 2023;29:516-519]
-
Ahn JC, Tran NH, Yang JD
- KMID: 2569163
- Clin Mol Hepatol.
- 2025 Jul;31(3):1103-1104.
- doi: 10.3350/cmh.2023.0051e
-
- CITED
-
- Close
- SHARE
-
- Close
- Preface
-
Jun DW
- KMID: 2559583
- Clin Mol Hepatol.
- 2024 Sep;30(Suppl):S4-S4.
- doi: 10.3350/cmh.2024.0598
-
- CITED
-
- Close
- SHARE
-
- Close
- Congratulatory remarks
-
Bae SH
- KMID: 2539782
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S1-S1.
- doi: 10.3350/cmh.2023.0027
-
- CITED
-
- Close
- SHARE
-
- Close
- Special thanks
-
Kim SU
- KMID: 2539785
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S4-S4.
- doi: 10.3350/cmh.2023.0010
-
- CITED
-
- Close
- SHARE
-
- Close
- Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
-
Thakral N, Simonetto
- KMID: 2501319
- Clin Mol Hepatol.
- 2020 Jan;26(1):74-77.
- doi: 10.3350/cmh.2018.0042
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum
-
No authors listed
- KMID: 2155298
- Clin Mol Hepatol.
- 2015 Mar;21(1):104-104.
- doi: 10.3350/cmh.2015.21.1.104
On page 358, There was an error in the legend of Figure 2. On page 373, There was an error in the Table 3. -
- CITED
-
- Close
- SHARE
-
- Close
- Preface
-
Kim SU
- KMID: 2559582
- Clin Mol Hepatol.
- 2024 Sep;30(Suppl):S3-S3.
- doi: 10.3350/cmh.2024.0595
-
- CITED
-
- Close
- SHARE
-
- Close
- Linvencovir: Paving the way for functional cure in hepatitis B
-
Yang J, Choi J
- KMID: 2554420
- Clin Mol Hepatol.
- 2024 Apr;30(2):164-165.
- doi: 10.3350/cmh.2024.0149
-
- CITED
-
- Close
- SHARE
-
- Close
- Letter regarding “Risk factors in nonalcoholic fatty liver disease”
-
Pratap A, More U, Phalak P, Deshmukh A
- KMID: 2546391
- Clin Mol Hepatol.
- 2023 Oct;29(4):1046-1047.
- doi: 10.3350/cmh.2023.0268
-
- CITED
-
- Close
- SHARE
-
- Close
- Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
-
Park JS, Bae SH
- KMID: 2507976
- Clin Mol Hepatol.
- 2020 Oct;26(4):577-578.
- doi: 10.3350/cmh.2020.0143
-
- CITED
-
- Close
- SHARE
-
- Close
- Congratulatory remarks
-
Kim W
- KMID: 2559581
- Clin Mol Hepatol.
- 2024 Sep;30(Suppl):S2-S2.
- doi: 10.3350/cmh.2024.0610
-
- CITED
-
- Close
- SHARE
-
- Close
- The management of polycystic liver disease by tolvaptan
-
Takenaka T, Miura S, Kitajima M
- KMID: 2501318
- Clin Mol Hepatol.
- 2020 Jan;26(1):70-73.
- doi: 10.3350/cmh.2019.0026
-
- CITED
-
- Close
- SHARE
-
- Close
- Elimination of hepatitis C: What would be the practical approach?
-
Yim HJ
- KMID: 2511457
- Clin Mol Hepatol.
- 2021 Jan;27(1):97-99.
- doi: 10.3350/cmh.2020.0304
-
- CITED
-
- Close
- SHARE
-
- Close
- A challenge in distinguishing between acute hepatitis Band acute exacerbation of chronic hepatitis B
-
Baek YH
- KMID: 2500389
- Clin Mol Hepatol.
- 2020 Apr;26(2):233-235.
- doi: 10.3350/cmh.2020.0039
-
- CITED
-
- Close
- SHARE
-
- Close
